5348042025-01-012025-03-315348042025-03-315348042024-03-315348042024-04-012025-03-315348042025-01-012025-03-31in-capmkt:OtherExpenses1Member5348042024-04-012025-03-31in-capmkt:OtherExpenses1Member5348042025-01-012025-03-31in-capmkt:ReportableSegments1Member5348042025-01-012025-03-31in-capmkt:ReportableSegments2Member5348042024-04-012025-03-31in-capmkt:ReportableSegments1Member5348042024-04-012025-03-31in-capmkt:ReportableSegments2Member5348042025-01-012025-03-31in-capmkt:ReportableSegments1Member5348042025-01-012025-03-31in-capmkt:ReportableSegments2Member5348042024-04-012025-03-31in-capmkt:ReportableSegments1Member5348042024-04-012025-03-31in-capmkt:ReportableSegments2Member5348042025-01-012025-03-31in-capmkt:ReportableSegments1Member5348042025-03-31in-capmkt:ReportableSegments1Member5348042025-01-012025-03-31in-capmkt:ReportableSegments2Member5348042025-03-31in-capmkt:ReportableSegments2Member5348042025-01-012025-03-31in-capmkt:ReportableSegments1Member5348042025-03-31in-capmkt:ReportableSegments1Member5348042025-01-012025-03-31in-capmkt:ReportableSegments2Member5348042025-03-31in-capmkt:ReportableSegments2Member5348042025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15348042024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15348042025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15348042024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15348042025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares534804CARERATINGNAINE752H01013CARE RATINGS LIMITEDMain BoardEquity2024-04-012025-03-312025-05-122025-05-02INRLakhsQuarterlyFourth quarterMulti segment2025-05-1212:00:002025-05-1219:00:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31UnauditedConsolidated10965090001517370001248246000000471171000596400030615000151644000659394000588852000058885200014216200012969000155131000043372100000004337210002634000436355000426096000762500042885000075050002993210001014.2414.170014.2414.172024-04-012025-03-31AuditedConsolidated40231750005075380004530713000000188924800021082000117217000580508000260805500019226580000192265800051643700062020005226390000140001900000001400019000-2629000139739000013723870002763200013698220002756800029932100010776336000045.8945.690045.8945.69Other expenses151644000Other expenses58050800079935700000795030003132760002924000000134071700001143400064289000141644000012500018234000265617500000320853000488152000481868000123920005502445000680571000041770000737870006921267000009577442000299321000776336000080626810009234400081550250000000204942000204942000173414000660160000044437200000151416000151416000304346000455762000450902000557740001560700009780450000014224170009577442000The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on May 12, 2025 and have been audited by the statutory auditors of the Company.The Board of Directors of the Company have recommended final dividend of Rs. 11 per share. The company had earlier paid Rs. 7 per share as interim dividend in Q2 FY25. Accordingly, the total dividend for FY25 shall be Rs. 18 per share.The consolidated financial results include results of CARE Ratings Limited and its subsidiaries namely CARE Analytics and Advisory Private Limited (formerly known as CARE Risk Solutions Private Limited), CARE ESG Ratings Limited (formerly known as CARE Advisory Research and Training Limited), CARE Ratings (Africa) Private Limited, CARE Ratings South Africa (Pty) Limited, CARE Ratings Nepal Limited and CareEdge Global IFSC Limited (w.e.f April 29, 2024).The accompanying financial results have been prepared as per the format prescribed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as modified by Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016.The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended from time to time) read with section 133 of the Companies Act, 2013.The Company has granted 8,11,500 options on various dates (including in previous periods) to the eligible employees of the Group under the Company's Employees Stock Option Scheme (ESOS) 2020 which are duly approved by shareholders in AGM and Nomination & Remuneration Committee. As per Ind AS 102 - Share Based Payment, total cost of ESOS 2020 is recognised over vesting period.Employee Benefit Expenses in Consolidated results includes ESOP charge under respective periods as under: Share based payment expenses for quarter is Rs. 30.01 lacs & year is Rs.187.67 lacs.The figures for the quarter ended March 31, 2024 in the above financial results are the balancing figures between the audited figures for the full financial year ended March 31, 2024 and the year to date unaudited limited reviewed figures published up to the nine months ended December 31, 2023.The figures for the quarter ended March 31, 2025 in the above financial results are the balancing figures between the audited figures for the full financial year ended March 31, 2025 and the year to date unaudited limited reviewed figures published up to the nine months ended December 31, 2024.Ratings and related services976101000Others122609000Ratings and related services3601215000Others425671000109871000040268860002201000371100010965090004023175000Ratings and related services554094000Others3163000Ratings and related services1958285000Others-728120005572570001885473000596400021082000-37559000-582670005888520001922658000Ratings and related services7704884000Others452338000815722200014202200009577442000Ratings and related services1057905000Others364513000142241800001422418000210820000006589900000-1465770000001077410000117217000000913770000-1690000176400045041000018767000-4363400008220000345140000-1866560001736002000000506463000012295390000000000001473770000000000000031055000892008000000017640004802710000-57987000-58428200000000042141000000119080005491120002108200000-5399610001052960000105296000382856000488152000Items that will not be reclassified to profit or Loss44280004428000Items that will not be reclassified to profit or Loss-3574000-35740005420004458000Items that will be reclassified to profit or Loss-1252000-1252000Items that will be reclassified to profit or Loss54030005403000002634000-2629000AuditedtrueM/s BSR & Co LLPtrue2025-07-31